2022
DOI: 10.1055/s-0042-1744422
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive Evaluation of the Current Knowledge on Breast Implant Associated-Anaplastic Large Cell Lymphoma

Abstract: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently spotlighted T-cell origin non-Hodgkin's lymphoma with an increasing incidence of over 800 cases and 33 deaths reported worldwide. Development of BIA-ALCL is likely a complex process involving many factors, such as the textured implant surface, bacterial biofilm growth, immune response, and patient genetics. As the incidence of BIA-ALCL is expected to increase, it is important for all surgeons and physicians to be aware of this di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 81 publications
0
5
0
Order By: Relevance
“…On the other hand, there are no confirmed cases of BIA-ALCL in patients in whom only smooth implants have been used. 45 However, these have a higher capsular contracture rate and risk of bottoming out. 46 In this study, all of our patients after the initial consultation chose textured implants and signed an informed consent including that these have been associated with BIA-ALCL (incidence rate is 0.33 per 1 million person-years in textured implants that use a negative-imprint stamping technique for texturization 43 ).…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, there are no confirmed cases of BIA-ALCL in patients in whom only smooth implants have been used. 45 However, these have a higher capsular contracture rate and risk of bottoming out. 46 In this study, all of our patients after the initial consultation chose textured implants and signed an informed consent including that these have been associated with BIA-ALCL (incidence rate is 0.33 per 1 million person-years in textured implants that use a negative-imprint stamping technique for texturization 43 ).…”
Section: Discussionmentioning
confidence: 99%
“…A similar result was described by Kricheldorff et al [69], who also reported the predominance of lymphoma-type cancer-more specifically, anaplastic large cell lymphoma (BIA-ALCL)-in women undergoing silicone breast implantation. BIA-ALCL is a type of non-Hodgkin's lymphoma that also originates from a silicone implant in the pectoral region of women [70]. Its genesis involves factors related to immunological interaction between tissue and prosthesis, bacterial growth in the implanted site, and genetic factors [70,71].…”
Section: Discussionmentioning
confidence: 99%
“…BIA-ALCL is a type of non-Hodgkin's lymphoma that also originates from a silicone implant in the pectoral region of women [70]. Its genesis involves factors related to immunological interaction between tissue and prosthesis, bacterial growth in the implanted site, and genetic factors [70,71].…”
Section: Discussionmentioning
confidence: 99%
“…With increasing incidence of BIA-ALCL, leading organizations, including the National Cancer Comprehensive Network and the Third World Consensus Conference, have appropriately raised awareness and provided guidelines for the diagnosis and treatment of BIA-ALCL in symptomatic patients. [19][20][21][22][23][24] However, the management for asymptomatic patients with textured devices remains unclear and is based primarily on expert opinions, such as those published by McGuire et al 14 Frojo et al recently conducted a study that surveyed The Aesthetic Society to investigate practice trends for management of asymptomatic cosmetic patients with textured implants, which demonstrated significant heterogeneity in nonoperative and operative management. 25 Similarly, our study evaluates current practice management trends, although focusing on the breast reconstruction population, who often have higher operative risk due to factors such as thin mastectomy flap coverage of implants, previous irradiation, and presence of ADM in the pocket.…”
Section: Takeawaysmentioning
confidence: 99%